Hemodynamic Assessment in Acute Decompensated Heart Failure
Hemodynamic Assessment Throughout Diuretic Treatment in Acute Decompensated Heart Failure
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.
All patients enrolled in the study will first provide written informed consent to participate and then the research coordinator will check that the subject meets all study inclusion criteria and does not meet any of the study exclusion criteria. Enrolled subjects will undergo up to six (6) hemodynamic assessment sessions lasting less than 90 minutes each over the course of their hospitalization. There will be at least eight (8) hours between assessment sessions.
Each assessment session includes recording of the subject's weight, measurements with the reference devices, and measurements with the novel optical system. During the session, the subject will be assessed in the supine, sitting, and standing positions. NT-proBNP measurements will be done at the start of study participation and the end. A market research questionnaire will be administered to the subject following the first measurement session.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Split, Kroatië, 21 000
- University Hospital of Split
-
-
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87102
- New Mexico Heart Institute
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age ≥ 18 years
- Admission to the hospital with a primary diagnosis of acute decompensated heart failure
- Treated with or planned treatment with intravenous diuretics
Volume overload, as indicated by at least one of the following clinical signs:
- Peripheral edema
- Pulmonary edema on physical examination
- Pleural effusions on chest x-ray
- Jugular venous distension on physical examination
- CVP > 10 cmH2O
- Presence of third heart sound
- Able to understand study procedures, agree to participate in the study program and voluntarily provide written informed consent
Exclusion Criteria:
- Inability or refusal to sign the Subject Informed Consent
- Age > 80 years
- Body mass index (BMI) > 40
- Planned mechanical ventilation during hospitalization
- Presence of left ventricular assist device (LVAD)
- Dialysis
- Pregnancy. All women of childbearing potential must have a negative pregnancy test before enrollment.
- Parenteral diuretic or other medical treatment for ADHF already administered for more than 12 hours prior to enrollment
- Skin damage to the optical sampling sites (fingers and dorsal hand), to include tattoos, scars, cuts, or burns extending over more than 30% of the visible tissue
- Compromised superficial hand veins or proximal venous stenosis
- Intravenous lines connected to both arms
- Inability to stand with support, if needed, for 4 minutes
- Inability to place hand in the venous imaging enclosure due to forearm, elbow, or shoulder injuries, or other physical constraints
- Inability to wear fingertip or ring sensors on three fingers (of either hand) due to missing fingers, injured fingers, or other physical constraints
- Persons in police custody or prisoners
- Major medical or psychiatric condition that would interfere with the ability to complete the study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Cohort
- Tijdsperspectieven: Dwarsdoorsnede
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Accuracy of Estimated Changes in Stroke Volume
Tijdsspanne: Retrospective up to 6 months after study completion
|
Comparison of Stroke Volume Measurement (units of ml) from the optical measurement system with paired Stroke Volume Measurement (ml) from the reference device.
Accuracy will be measured in percentage error and Bland-Altman limits of agreement.
|
Retrospective up to 6 months after study completion
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Accuracy of Central Venous Pressure Measurement
Tijdsspanne: Retrospective up to 6 months after study completion
|
Comparison of Central Venous Pressure Measurement (units of cmH2O) from the optical measurement system with paired Central Venous Pressure Measurement (cmH2O) from the reference device.
Accuracy will be measured in percentage error and Bland-Altman limits of agreement.
|
Retrospective up to 6 months after study completion
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Elena Allen, PhD, Rodin Scientific
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RS-2018-S01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .